Arg! Why was this not double blinded - even single blinded would have been better than this. The major risk in any machine learning approach is over training and leave-one-out cross validation puts you at very high risk of over training.
Will be good for a trade - I just missed out buying in on the opening.
Ann: Positive Results from Australian Adult Clinical Studies, page-11
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #